APA (7th ed.) Citation

Boris Grinshpun, Nels Thorsteinson, Joao NS Pereira, Friedrich Rippmann, David Nannemann, Vanita D. Sood, & Yves Fomekong Nanfack. (2021). Identifying biophysical assays and in silico properties that enrich for slow clearance in clinical-stage therapeutic antibodies. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Boris Grinshpun, Nels Thorsteinson, Joao NS Pereira, Friedrich Rippmann, David Nannemann, Vanita D. Sood, and Yves Fomekong Nanfack. Identifying Biophysical Assays and in Silico Properties That Enrich for Slow Clearance in Clinical-stage Therapeutic Antibodies. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Boris Grinshpun, et al. Identifying Biophysical Assays and in Silico Properties That Enrich for Slow Clearance in Clinical-stage Therapeutic Antibodies. Taylor & Francis Group, 2021.